Transcatheter Aortic Valve Intervention-Live Transmission

NCT01353287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2013-08-01

No results posted yet for this study

Summary

The primary objective of this clinical trial is to evaluate safety of patients who underwent Transcatheter Aortic Valve Intervention (TAVI) during a live case or video-taped transmission as compared to those without procedure transmission.

Conditions

  • Aortic Valve Disorder

Sponsors & Collaborators

  • Food and Drug Administration (FDA)

    collaborator FED
  • Medstar Health Research Institute

    lead OTHER

Principal Investigators

  • Ron Waksman, MD · Washington Hospital Center, Washington, DC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States
  • Canada
  • Germany
  • Italy
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01353287 on ClinicalTrials.gov